- ThinkEquity upgraded InterMune (ITMN) to buy from hold following the FDA advisory committee's approval of Esbriet. InterMune was also upgraded to outperform from market perform at Wells Fargo.
- Piper Jaffray upgraded Radian (RDN) to neutral from underweight with a $9 target. The firm believes the company will not have to raise capital as the government is allowing it to increase its leverage ratio beyond historic maximum levels.
- JPMorgan upgraded ExlService (EXLS) to neutral from underweight following the company's Q4 results.
- Lockheed Martin (LMT) was upgraded to neutral from underperform at Macquarie.
- Analog Devices (ADI) was upgraded to outperform from market perform at Bernstein.
- Goodrich (GR) was upgraded to conviction buy from buy at Goldman.
Analyst Downgrades
- Merriman downgraded Facet Biotech (FACT) to neutral from buy after the company agreed to be acquired by Abbott Laboratories (ABT).
- Citigroup downgraded J.Crew (JCG) to hold from buy on valuation following the company's Q4 results. Despite the downgrade, the firm raised its target for shares to $50 from $49.
- Soleil downgraded Comerica (CMA) to hold from buy following the company's capital raise. The firm lowered its target for shares to $37 from $40.
- Barclays (BCS) was downgraded to market perform from outperform at FBR Capital.
- Chevron (CVX) was downgraded to neutral from buy at BofA/Merrill.
- Vale SA (VALE) was downgraded to neutral from buy at UBS.
Analyst Initiations
- Netflix (NFLX) was started at Canaccord with a buy rating and $85 target.
- Ingram Micro (IM) was assumed with a hold rating and $20 target at Kaufman Bros.
- Benchmark initiated Cubic (CUB) with a buy rating and $42 target.
- Evergreen Solar (ESLR) was initiated with a hold rating at Wunderlich.
- Captone initiated WGL Holdings (WGL) with a hold rating and $38 target.
- Trimble Navigation (TRMB) was initiated with a market perform rating at Morgan Keegan.
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal


